Messrs WGND, please let me briefly present myself: I am a Senior Clinical Research Associate from 16 years, with an experience of about 90 worldwide clinical trials. I am also the founder R-Evolution Group, an organization of clinical research experts with a deep knowledge and field experience in the management of GCP/FDA clinical trials of new therapies, operating in more than 30 countries, mainly covering the countries listed by WHO as TB and MDR-TB highest incidence countries. We provide all kind of support needed to manage clinical trials in the countries with highest incidence of tuberculosis, MDR-tuberculosis, and XDR-tuberculosis, especially in Europe, Eastern Europe and Africa. Please, I would like to get information on how I can become member of WGND as I feed the capacity building for the creation of an environment that can trigger virtuous paths promoting highest quality standards tuberculosis clinical trials. We would like to strengthen partnerships with private and public stakeholders involved in the TB, MDR-TB, and XDR-TB clinical research, linking the interests of Stakeholders, Researchers, Networks, Small & Medium Enterprises, Start-Ups, Spin-Off, Investors, Patients\' Associations, Advocates, Academia, Institutions, International Organizations Policy/Decision Makers, Funding Agencies, and Vendors/Providers of Services, thus creating synergistic connections to promote tuberculosis clinical research. For this reason I am already collaborating with STOP TB Partnership, TB Europe Coalition, and I am member of The Union (IUATLD). Many thank for your attention, Kind regards, Dario Scaramuzzi R-Evolution Group EEIG, Founder mob.: +39 347 3631971 ph.: +39 0836 801731 fax: +39 02 700426857 mail: d.scaramuzzi@r-evolutiongroup.org www.r-evolutiongroup.org